Shamburg News · 8-K filed Oct 6, 2026, 4:57 PM EDT
Nuo Therapeutics Closes $325,000 Second Funding Under Loan Agreement; Director Pittman Participates
AURX · Nuo Therapeutics, Inc.
- Material agreement
- Financing
- Materiality: medium
On October 6, 2026, Nuo Therapeutics closed the $325,000 Second Funding under its Amended and Restated Loan and Security Agreement, following an Assignment, Joinder, and Amendment No. 1 that also enabled a $100,000 commitment assignment and three new lenders. The Company states it has received an aggregate $2,000,000 from Lenders under the Loan Agreement. Director and more than 10% holder Scott M. Pittman assumed $25,000 of the assigned commitment and received warrants for 4,500 Shares and 458 Shares of prepayment warrants, plus an interest warrant for up to 2,750 Shares.
Source: SEC EDGAR, Form 8-K, Items 1.01, 2.03, 3.02, 9.01, accession 0001437749-26-032242.
Written from the filing by Shamburg Markets. Figures are as reported by the company.